We are happy to share that Comac Medical has been assigned with conducting Phase 2 randomized, placebo-controlled GULLIVER-2 trial. The results of the study were presented at AASLD The Liver Meeting on 4th-8th November.
Check the results in the following document.
Comac Medical presents newly available data of successfully completed clinical trials at AASLD The Liver Meeting
November 28, 2022
Share:
News
Planning a clinical trial comes with numerous challenges, requiring a methodical approach for successful execution. However, unforeseen issues...
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading...